ArticleAmbio2026
Pathways to bioeconomy development: A multi-regional perspective from Europe.
Article in Ambio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The transition towards a sustainable future is increasingly understood to rely on further development of the bioeconomy. In this, both public and private sectors play pivotal roles. Government agencies and public institutions are instrumental in shaping the trajectory of the bioeconomy through strategic frameworks, regulatory measures, and policies. These instruments may create a conducive environment by clearing away bureaucratic impediments and establishing favourable conditions. Concurrently, private sector entities, including industry interest groups and companies, have the important task of advocating for these favourable conditions and driving the bioeconomy's growth through active involvement, strategic business decisions, capital investments, and bringing bio-based innovations to market. Throughout these processes, perceptions of the bioeconomy held by actors in both sectors shape the outcomes of their actions. Hence, this study delves into the perceptions of the bioeconomy among stakeholders from both the public and private sectors across nine European regions regarding barriers and supporting conditions impacting its development, particularly important bioeconomy value chains, and the willingness and perceived responsibility to advance the bioeconomy. Findings from 534 online survey responses (288 public sector and 246 private sector) reveal that key factors identified as propelling the development of the bioeconomy forward include access to investment and scientific knowledge, while obstacles such as limited cooperation among stakeholders and inadequate supportive policies and legislative environments were noted as primary hindrances. Among the value chains highlighted, bioenergy was frequently recognised as having high growth potential, while not necessarily being the one with the most significant environmental benefits. Both the public and the private sector demonstrated a high willingness to develop the bioeconomy, yet both also assigned more responsibility to the public sector in three main areas: enhancing societal awareness and communication about the bioeconomy, ensuring beneficial environmental and social impacts, and investing in the bioeconomy's growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.